Condition: Breast Cancer · Sponsor: Canadian Cancer Trials Group
This study is being done to answer the following question: Can testing breast cancer for DNA abnormalities or "biomarkers" help predict which patients are most likely to be helped by certain treatments? The pre-study screening is being done to test a sample of blood (or tumour tissue) for biomarkers to see if patients can participate in the study
This description comes directly from the study's public registry record.
Lesley Seymour · 613-533-6430 · lseymour@ctg.queensu.ca
Laura Pearce · 613-533-6430 · lpearce@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary, Alberta, Canada | Recruiting |
| BCCA - Kelowna | Kelowna, British Columbia, Canada | Recruiting |
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Recruiting |
| QEII Health Sciences Centre | Halifax, Nova Scotia, Canada | Recruiting |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton, Ontario, Canada | Recruiting |
| Kingston Health Sciences Centre | Kingston, Ontario, Canada | Recruiting |
| Ottawa Hospital Research Institute | Ottawa, Ontario, Canada | Recruiting |
| Odette Cancer Centre | Toronto, Ontario, Canada | Suspended |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
| The Jewish General Hospital | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05601440